April 27 set for Guidant shareholder vote on Johnson & Johnson deal:
This article was originally published in Clinica
Executive Summary
Guidant's shareholders will vote on the proposed merger of the company with Johnson & Johnson on April 27. All shareholders on record as of March 21 will be eligible to vote on the $25.4bn ($23.9bn net) deal, which was announced in December 2004. The transaction is still being scrutinised by the US and European antitrust authorities.